Position in XENE
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$27,708,126
+$9,000,169 QoQ
Shares Held
476,494
+14.2% QoQ
Ownership
0.493%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $1,920,933,361 across 79 Biotechnology names. XENE ranks #23 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
186,388 | $144,010,824 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,915 | $102,219,704 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
259,731 | $77,132,315 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
224,330 | $74,224,067 | |
| 5 | INSM |
INSMED Inc
|
401,735 | $65,691,707 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,516,297 | $58,362,271 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
580,677 | $56,470,838 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,001,976 | $55,454,735 |
All Filings in XENE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,708,126 | 476,494 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $18,707,957 | 417,402 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $15,924,935 | 396,636 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,414,706 | 396,636 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $15,253,507 | 454,650 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,293,495 | 492,181 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $18,262,207 | 463,861 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,346,385 | 521,836 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $24,146,056 | 560,884 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $24,452,517 | 530,884 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,467,237 | 569,884 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $27,176,534 | 705,884 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $25,740,382 | 719,206 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,015,906 | 735,884 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $27,467,912 | 760,884 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $26,256,718 | 863,140 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $18,472,044 | 604,254 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $16,573,163 | 530,511 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,936,232 | 715,722 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $13,326,743 | 715,722 | Shares | Sole | 2021-07-20 | |
| No filing history on record for this holder in this stock. | ||||||